{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:36:17Z","timestamp":1767846977415,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41409-018-0374-3","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T17:57:21Z","timestamp":1540490241000},"page":"1022-1028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT"],"prefix":"10.1038","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4332-0114","authenticated-orcid":false,"given":"Ivan S.","family":"Moiseev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Tsvetkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randa M","family":"Alnounou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Bogardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Chalandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-8316","authenticated-orcid":false,"given":"Mikhail Yu.","family":"Drokov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Dvirnyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-501X","authenticated-orcid":false,"given":"Maura","family":"Faraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone Smidstrup","family":"Friis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildegard T.","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian Thomas","family":"Kornblit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Koelper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7025-1735","authenticated-orcid":false,"given":"Christian","family":"Koenecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-1103","authenticated-orcid":false,"given":"Dietger","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob R.","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Peczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Penack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zinaida","family":"Peric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Piekarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola Erminia","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Rovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Rzepecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Sigrist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanna M.","family":"Siitonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Stoelzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazimierz","family":"Sulek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios A.","family":"Tsakiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula","family":"Wilkowojska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael F","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapani","family":"Ruutu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-8180","authenticated-orcid":false,"given":"Grzegorz W","family":"Basak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"374_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2215\/CJN.02070508","volume":"4","author":"S Changsirikulchai","year":"2009","unstructured":"Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol. 2009;4:345\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"key":"374_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood. 2014;124:645\u201353.","journal-title":"Blood"},{"key":"374_CR3","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","volume":"130","author":"NJ Gloude","year":"2017","unstructured":"Gloude NJ, Khandelwal P, Luebbering N, Lounder DT, Jodele S, Alder MN, et al. Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD. Blood. 2017;130:1259\u201366.","journal-title":"Blood"},{"key":"374_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jca.21352","volume":"30","author":"S Mulay","year":"2015","unstructured":"Mulay S, Kreuter JD, Bryant SC, Elliott MA, Hogan WJ, Winters JL, et al. Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant. J Clin Apher. 2015 ;30:147\u201353.","journal-title":"J Clin Apher"},{"key":"374_CR5","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/TP.0000000000000601","volume":"99","author":"FS Fontbrune de","year":"2015","unstructured":"de Fontbrune FS, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, et al. Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC. Transplantation. 2015;99:1953\u20139.","journal-title":"Transplantation"},{"issue":"4","key":"374_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41409-018-0293-3","volume":"54","author":"Sarah Kraft","year":"2018","unstructured":"Kraft S, Bollinger N, Bodenmann B, Heim D, Bucher C, Lengerke C et al. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease. Bone Marrow Transplant. 2018. \n                    https:\/\/doi.org\/10.1038\/s41409-018-0293-3.\n                    \n                   [Epub ahead of print].","journal-title":"Bone Marrow Transplantation"},{"key":"374_CR7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/bmt.2016.87","volume":"51","author":"S Vasu","year":"2016","unstructured":"Vasu S, Wu H, Satoskar A, Puto M, Roddy J, Blum W, et al. Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy. Bone Marrow Transplant. 2016;51:1241\u20134.","journal-title":"Bone Marrow Transplant"},{"key":"374_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/trf.13437","volume":"56","author":"H Fujiwara","year":"2016","unstructured":"Fujiwara H, Maeda Y, Sando Y, Nakamura M, Tani K, Ishikawa T, et al. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin. Transfusion. 2016;56:886\u201392.","journal-title":"Transfusion"},{"key":"374_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","volume":"54","author":"S Jodele","year":"2016","unstructured":"Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G, et al. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transfus Apher Sci. 2016;54:181\u201390.","journal-title":"Transfus Apher Sci"},{"key":"374_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:571\u20135.","journal-title":"Biol Blood Marrow Transplant"},{"key":"374_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3324\/haematol.10699","volume":"92","author":"T Ruutu","year":"2007","unstructured":"Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007;92:95\u2013100.","journal-title":"Haematologica"},{"key":"374_CR12","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1097\/01.TP.0000141363.81600.0D","volume":"78","author":"T Hahn","year":"2004","unstructured":"Hahn T, Alam AR, Lawrence D, Ford L, Baer MR, Bambach B, et al. Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion. Transplantation. 2004;78:1515\u201322.","journal-title":"Transplantation"},{"key":"374_CR13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/sj.bmt.1705160","volume":"36","author":"MT Martinez","year":"2005","unstructured":"Martinez MT, Bucher Ch, Stussi G, Heim D, Buser A, Tsakiris DA, et al. Transplant-associated microangiopathy (TA-TMA) in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant. 2005;36:993\u20131000.","journal-title":"Bone Marrow Transplant"},{"key":"374_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","volume":"11","author":"C Cutler","year":"2005","unstructured":"Cutler C, Henry NL, Magee C, Li S, Kim HT, Alyea E, et al. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:551\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"key":"374_CR15","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.bbmt.2005.07.012","volume":"11","author":"GA Hale","year":"2005","unstructured":"Hale GA, Bowman LC, Rochester RJ, Benaim E, Heslop HE, Krance RA, et al. Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children. Biol Blood Marrow Transplant. 2005;11:912\u201320.","journal-title":"Biol Blood Marrow Transplant"},{"key":"374_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/bmt.2009.230","volume":"45","author":"E Willems","year":"2010","unstructured":"Willems E, Baron F, Seidel L, Frere P, Fillet G, Beguin Y. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplant. 2010;45:689\u201393.","journal-title":"Bone Marrow Transplant"},{"key":"374_CR17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.bbmt.2010.02.006","volume":"16","author":"IG Glezerman","year":"2010","unstructured":"Glezerman IG, Jhaveri KD, Watson TH, Edwards AM, Papadopoulos EB, Young JW, et al. Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2010;16:976\u201384.","journal-title":"Biol Blood Marrow Transplant"},{"key":"374_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbmt.2008.11.004","volume":"15","author":"U Platzbecker","year":"2009","unstructured":"Platzbecker U, von Bonin M, Goekkurt E, Radke J, Binder M, Kiani A, et al. Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial. Biol Blood Marrow Transplant. 2009;15:101\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"374_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90:918\u201326.","journal-title":"Transplantation"},{"key":"374_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3324\/haematol.2012.069559","volume":"98","author":"J Labrador","year":"2013","unstructured":"Labrador J, Lopez-Anglada L, Perez-Lopez E, Lozano FS, Lopez-Corral L, Sanchez-Guijo FM, et al. Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients. Haematologica. 2013;98:437\u201343.","journal-title":"Haematologica"},{"key":"374_CR21","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118:1452\u201362.","journal-title":"Blood"},{"key":"374_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1751-553X.2011.01380.x","volume":"34","author":"G. Zini","year":"2012","unstructured":"G. Zini, G. d\u2019onofrio, C. Briggs, W. Erber, J. M. Jou, S. H. Lee, S. McFadden, J. L. Vives-Corrons, N. Yutaka, J. F. Lesesve. ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. International Journal of Laboratory Hematology. 2012;34:107-116","journal-title":"International Journal of Laboratory Hematology"},{"key":"374_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1751-553X.2010.01292.x","volume":"33","author":"JF Lesesve","year":"2011","unstructured":"Lesesve JF, Alla F, Dugue F, Salignac S, Clement L, Lecompte T, et al. Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation. Int J Lab Hematol. 2011;33:343\u201356.","journal-title":"Int J Lab Hematol"},{"key":"374_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/ijlh.12364","volume":"37","author":"JF Lesesve","year":"2015","unstructured":"Lesesve JF, Speyer E, Perol JP. Fragmented red cells reference range for the Sysmex XN\u00ae-series of automated blood cell counters. Int J Lab Hematol. 2015;37:583\u20137.","journal-title":"Int J Lab Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0374-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:13:24Z","timestamp":1684617204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0374-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0374-3","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"29 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"ISM had received travel grants from MSD, Novartis, Pfizer, Celgene, Takeda, BMS, consulting fees from Novartis and Celgene, lecturer fees from Novartis. OP has received honoraria and travel support from Astellas, Gilead, Jazz, MSD, Neovii Biotech and Pfizer. He has received research support from Bio Rad, Gilead, Jazz, Neovii Biotech, Pierre Fabre, Sanofi and Takeda. He is member of the advisory board to Alexion, Jazz, Gilead, MSD and Omeros. GWB is the member of the advisory board to Omeros. The\u00a0other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}